Apollo Health Ventures
Apollo Health Ventures is a transatlantic early-stage venture capital firm focused on co-founding and investing in transformative healthcare companies. The firm targets age-related diseases and the biology of aging, aiming to enhance healthy lifespan and reduce healthcare spending. By leveraging biotechnology and scientific breakthroughs, Apollo Health Ventures seeks to impact human health significantly within the next decade.
Apollo Health Ventures
What We Do
Apollo Health Ventures partners with scientific experts to turn untapped technologies into transformational companies, acquiring founder shares at nominal value and offering unique upsides to investors.
The firm identifies and invests in best-in-class companies at an early stage, helping them accelerate based on breakthrough science and leadership.
Apollo provides scientific and operational expertise to its portfolio companies, helping them build top teams and access capital and strong syndicates.
The firm conducts 'killer experiments' to minimize risks in its investments.
Apollo supports its portfolio companies with talent and leadership recruitment, guidance on R&D, and clinical trial and indication selection strategies.
Investment Range
Portfolio
Developing innovative therapies for rare and aging-related diseases, focusing on selective mTORC1 inhibitors.
#Biotechnology
Focused on developing novel cancer therapies targeting cellular plasticity, using a machine learning, multi-omics based platform.
#Biotechnology
Developing BL-001, a potential first-in-class therapeutic for Dravet Syndrome and ALS.
#Biotechnology
Launched with $15 M seed financing to pioneer new class of proteasome activator medicines.
#Biotechnology
Focused on advancing FOXO4-Therapeutics pipeline for treating cancer and chronic diseases.
#Biotechnology
A new cellular reprogramming startup unveiled in collaboration with Paul Scherrer Institute.
#Biotechnology
Key People
Co-Founder & General Partner
Co-Founder & General Partner
Partner